Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Mild to Moderate Alzheimer's Disease Treatment Study
Clinical Trial Protocol ID
11120605

Clinical Trial Investigator Name
Raj C. Shah

Clinical Trial Title

BACE1 Inhibitor Treatment Study in Individuals with Mild to Moderate Alzheimer’s Disease



Clinical Trial Protocol Description

The purpose of this 20-month trial is to evaluate the safety and effectiveness of multiple doses of an experimental drug compared to placebo when given to people with Alzheimer’s disease. At Rush University Medical Center, we anticipate recruiting approximately 18 people. Treatment or matching placebo will be assigned randomly.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are 55 to 85 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a study partner willing to accompany you to all study visits

You will be excluded from this study if you:

  • Are unwilling or unable to undergo multiple MRI scans
  • Have medical conditions that are not stable or that require adjustments of your medications

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.





Contact Name Pat Samuels
Contact Phone (312) 942-3033
Promotional Information

Clinical Trials Home
Alzheimer's Disease Trials
Mild to Moderate Alzheimer's Disease Treatment Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois